Cancellation of state registration. Prednisolone Nycomed

March 22, 2017
Active substances:
Trade names:
ICD-10:
I.B15-B19.B17.1    Acute hepatitis C
I.B15-B19.B16    Acute hepatitis B
I.B15-B19.B18.2    Chronic viral hepatitis C
I.B15-B19.B18    Chronic viral hepatitis
II.C81-C96.C81    Hodgkin's disease [lymphogranulomatosis]
II.C81-C96.C91.0    Acute lymphoblastic leukemia
II.C81-C96.C92.0    Acute myeloid leukemia
III.D55-D59.D59    Acquired hemolytic anemia
III.D65-D69.D69.3    Idiopathic thrombocytopenic purpura
III.D70-D77.D70    Agranulocytosis
IV.E15-E16.E16.1    Other forms of hypoglycemia
IV.E20-E35.E25    Adrenogenital disorders
IV.E20-E35.E27.1    Primary insufficiency of the adrenal cortex
IV.E20-E35.E27.4    Other and unspecified adrenocortical insufficiency
VII.H00-H06.H01.0    Blepharitis
VII.H10-H13.H10.1    Acute atopic conjunctivitis
VII.H10-H13.H10.4    Chronic conjunctivitis
VII.H10-H13.H10.5    Blepharoconjunctivitis
VII.H15-H22.H15.0    Sclerite
VII.H15-H22.H15.1    Episcleritis
VII.H15-H22.H16    Keratite
VII.H15-H22.H16.2    Keratoconjunctivitis
VII.H15-H22.H20.0    Acute and subacute iridocyclitis
VII.H15-H22.H20.1    Chronic iridocyclitis
VII.H30-H36.H30    Chorioretinal inflammation
X.J40-J47.J45    Asthma
X.J40-J47.J46    Asthmatic status [status asthmaticus]
XI.K70-K77.K72    Hepatic failure, not elsewhere classified
XI.K70-K77.K73    Chronic hepatitis, not elsewhere classified
XII.L10-L14.L10    Pemphigus [pemphigus]
XII.L20-L30.L20.8    Other atopic dermatitis
XII.L20-L30.L21    Seborrheic dermatitis
XII.L20-L30.L26    Exfoliative dermatitis
XII.L20-L30.L28.1    Scabby nodosum
XII.L20-L30.L28.2    Other scrapes
XII.L20-L30.L29    Itching
XII.L40-L45.L40    Psoriasis
XII.L50-L54.L53    Other erythematous conditions
XII.L60-L75.L63    Alopecia areata
XII.L80-L99.L93.0    Discoid lupus erythematosus
XIII.M05-M14.M05    Seropositive rheumatoid arthritis
XIII.M15-M19.M15    Polyarthrosis
XIII.M30-M36.M30    Nodular polyarteritis and related conditions
XIII.M30-M36.M32    Systemic lupus erythematosus
XIII.M30-M36.M33    Dermatopolymiositis
XIII.M30-M36.M34    Systemic sclerosis
XIII.M45-M49.M45    Ankylosing spondylitis
XIII.M50-M54.M54.3    Sciatica
XIII.M65-M68.M65    Synovitis and tenosynovitis
XIII.M70-M79.M70    Diseases of soft tissues associated with exercise, overload and pressure
XIII.M70-M79.M71    Other bursopathies
XIII.M70-M79.M72.0    Palmar fascial fibromatosis [Depuitrena]
XIII.M70-M79.M75.0    Adhesive shoulder capsulitis
XIX.T66-T78.T78.2    Anaphylactic shock, unspecified
XIX.T66-T78.T78.3    Angioedema
XIX.T80-T88.T80.5    Anaphylactic shock associated with the administration of serum
Prednisolone, glucocorticosteroid, rheumatoid arthritis, anaphylactic shock, asthmatic status, asthma, leukemia, hepatitis, eye diseases, systemic lupus erythematosus, angioedema

The Ministry of Health of the Russian Federation in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N015850 / 01 dated 28.05.2009 issued by Takeda Austria GmbH, Austria):

Prednisolone Nycomed (trade name of the drug)

Prednisolone (international non-proprietary, or grouping, or chemical name medicinal product)

solution for intravenous and intramuscular administration, 25 mg / ml (dosage form, dosage)

Takeda Austria GmbH, Austria St.Peter-Strasse 25, A-4020 Linz, Austria (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing by an authorized legal entity OOO Takeda Pharmaceuticals, Russia cancellation state registration of medicinal product.